Immunomodulating peptides

[1]  T. Nogimori,et al.  Tuftsin stimulates thyrotropin secretion in rats , 1985, Experientia.

[2]  I. Fidler,et al.  Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide. , 1985, Science.

[3]  H. Umezawa,et al.  Low molecular weight immunomodifiers produced by microorganisms. , 1985, International journal of clinical pharmacology, therapy, and toxicology.

[4]  T. Edgington,et al.  A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. , 1985, Journal of immunology.

[5]  M. Rola-Pleszczynski,et al.  Induction of cytotoxic cell activity by peptide fragments of beta 2-microglobulin. , 1985, Immunopharmacology.

[6]  J. Wybran.  Enkephalins and endorphins as modifiers of the immune system: present and future. , 1985, Federation proceedings.

[7]  E. M. Smith,et al.  A complete regulatory loop between the immune and neuroendocrine systems. , 1985, Federation proceedings.

[8]  A. Capron,et al.  Regulatory role of a tripeptide (TKP) from the second constant domain of immunoglobulin G--I. Inhibition of rat and human macrophage activities. , 1985, International journal of immunopharmacology.

[9]  P. Jollès,et al.  Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. , 1984, European journal of biochemistry.

[10]  E. Goetzl,et al.  Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. , 1984, Journal of immunology.

[11]  M. Flegel,et al.  The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide. , 1984, Methods and findings in experimental and clinical pharmacology.

[12]  E. Goetzl,et al.  Substance P recognition by a subset of human T lymphocytes. , 1984, The Journal of clinical investigation.

[13]  J. Krueger,et al.  Specific absorption with monoclonal antibodies to muramyl dipeptide of the pyrogenic and somnogenic activities of rabbit monokine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Okada,et al.  Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156. , 1984, Chemical & pharmaceutical bulletin.

[15]  T. Waldmann,et al.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Hoffman,et al.  Identification of macrophage receptors for angiotensin: a potential role in antigen uptake for T lymphocyte responses? , 1984, Journal of immunology.

[17]  W. Bessler,et al.  The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala). , 1984, Biochemical and biophysical research communications.

[18]  A. Adam,et al.  Muramyl peptides: Immunomodulators, sleep factors, and vitamins , 1984, Medicinal research reviews.

[19]  E. Goetzl,et al.  Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. , 1984, Cellular immunology.

[20]  G. Greenberg,et al.  Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. , 1984, Journal of immunology.

[21]  A. Goldstein,et al.  Thymosins: structure, function and therapeutic applications. , 1984, Thymus.

[22]  Z. Wieczorek,et al.  Immunologically active nonapeptide fragment of a proline-rich polypeptide from ovine colostrum: amino acid sequence and immunoregulatory properties. , 1983, Molecular immunology.

[23]  E. Goetzl,et al.  Specific stimulation of human T lymphocytes by substance P. , 1983, Journal of immunology.

[24]  M. Nishida,et al.  Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice. , 1983, The Journal of antibiotics.

[25]  K. Nakahara,et al.  Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives. , 1983, The Journal of antibiotics.

[26]  L. Chedid,et al.  Mise en évidence d'une structure bactérienne dans deux médiateurs humains: un facteur favorisant le sommeil et une monokine , 1983 .

[27]  M. Fridkin,et al.  ANTINEOPLASTIC, IMMUNOGENIC AND OTHER EFFECTS OF THE TETRAPEPTIDE TUFTSIN: A NATURAL MACROPHAGE ACTIVATOR , 1983 .

[28]  G. Renoux.  The thymic factor system. , 1983, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  I. Lamster,et al.  Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms. , 1982, Life sciences.

[30]  E. M. Smith,et al.  Regulation of the in vitro antibody response by neuroendocrine hormones. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Edgington,et al.  Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides. , 1982, Journal of immunology.

[32]  S. Okada,et al.  TOTAL SYNTHESIS OF FK‐156 ISOLATED FROM A STREPTOMYCES AS AN IMMUNOSTIMULATING PEPTIDE: APPLICATION OF A NOVEL COPPER CHELATE AMINO PROTECTION , 1982 .

[33]  E. Lederer,et al.  Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity , 1982, Infection and immunity.

[34]  S. Balcerzak,et al.  Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. , 1981, Journal of immunology.

[35]  H. Umezawa.  Small molecular immunomodifiers of microbial origin : fundamental and clinical studies of bestatin , 1981 .

[36]  P. Jollès,et al.  Immunostimulating substances from human casein. , 1981, Journal of immunopharmacology.

[37]  G. Beaurain,et al.  In vitro characteristics on human lymphocyte functions of a new immunomodulatory agent, a cyclic peptide, cyclomunine. , 1980, Clinical and experimental immunology.

[38]  S. Szmigielski,et al.  Immunosuppressive effect of vasoactive peptides derived from human fibrinogen. , 1980, Thrombosis research.

[39]  P. Jollès,et al.  A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar. , 1980, Life sciences.

[40]  E. Lederer,et al.  Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs , 1980, Infection and immunity.

[41]  P. Cuatrecasas,et al.  Specific nonopiate receptors for beta-endorphin. , 1979, Science.

[42]  T. Appelboom,et al.  Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. , 1979, Journal of immunology.

[43]  Z. Wieczorek,et al.  Proline-rich polypeptide from ovine colostrum: its effect on skin permeability and on the immune response. , 1979, Immunology.

[44]  H. Sekino,et al.  Inhibition effect of rosette formation between human lymphocytes and sheep erythrocytes by specific heptapeptide isolated from uremic fluid and its analogs. , 1979, Biochemical and biophysical research communications.

[45]  K. Shimada,et al.  Binding sites for angiotensin II in human mononuclear leucocytes. , 1978, Journal of biochemistry.

[46]  H. Pees,et al.  Immunosuppression by micromolecular fibrinogen degradation products in cancer , 1976, Nature.

[47]  V. Braun,et al.  Covalent lipoprotein from the outer membrane of Escherichia coli. , 1975, Biochimica et biophysica acta.

[48]  F. Franek,et al.  Isolation and characterization of a proline‐rich polypeptide from ovine colostrum , 1974, FEBS letters.

[49]  E. Lederer,et al.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. , 1974, Biochemical and biophysical research communications.

[50]  P. Jollès,et al.  Contribution to the study of the structure of adjuvant active waxes D from mycobacteria: Isolation of a peptidoglycan , 1968, FEBS letters.

[51]  A. Goldstein,et al.  Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Miller,et al.  Immunological function of the thymus. , 1961, Lancet.